Kevin R Kearney

Title: Kevin R Kearney: Innovator in Nucleic Acid Hybridization

Introduction

Kevin R Kearney is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of nucleic acid hybridization, holding a total of 5 patents. His work has advanced the methods used in detecting target nucleic acids, which is crucial for various applications in biotechnology and molecular biology.

Latest Patents

Among his latest patents, Kearney has developed hybridization promotion reagents. These novel reagents are designed for use in nucleic acid hybridization assays, facilitating the detection of target nucleic acids in samples. The most preferred reagent is a mixture of guanidinium thiocyanate and tetramethylammonium:Trifluoracetate. This mixture possesses unique properties that enhance hybridization between target nucleic acids and nucleic acid probes, leading to the phenomenon of superstoichiometric labeling.

Career Highlights

Kearney's career has been marked by his association with Amoco Corporation, where he has applied his expertise in the development of innovative solutions in the field of molecular biology. His work has not only contributed to scientific advancements but has also positioned him as a key figure in the industry.

Collaborations

Throughout his career, Kearney has collaborated with notable colleagues, including David Robinson and Ernest Bate. These collaborations have further enriched his research and development efforts, leading to impactful innovations in nucleic acid hybridization.

Conclusion

Kevin R Kearney's contributions to the field of nucleic acid hybridization through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in biotechnology and molecular biology.